Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | CytomX Therapeutics, Inc. CTMX | FMR LLC | 20,519,967 12.400% | 5,123,767![]() (+33.28%) | Filing History |
| 2025-11-05 11:30 am Purchase | 2025-09-30 | 13G | CytomX Therapeutics, Inc. CTMX | FMR LLC | 15,396,200 9.300% | 6,157,332![]() (+66.65%) | Filing History |
| 2025-08-21 4:00 pm Purchase | 2025-08-14 | 13G | CytomX Therapeutics, Inc. CTMX | Perceptive Advisors LLC | 9,680,185 5.900% | 7,103,142![]() (+275.63%) | Filing History |
| 2025-08-14 6:07 pm Purchase | 2025-06-30 | 13G | CytomX Therapeutics, Inc. CTMX | ORBIMED ADVISORS LLC | 8,461,500 5.400% | 8,461,500![]() (New Position) | Filing History |
| 2025-08-14 5:30 pm Sale | 2025-06-30 | 13G | CytomX Therapeutics, Inc. CTMX | Point72 Asset Management, L.P. | 8,084,623 5.100% | -5,009,777![]() (-38.26%) | Filing History |
| 2025-08-14 4:15 pm Purchase | 2025-06-30 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL MANAGEMENT, LLC | 11,065,662 7.000% | 4,347,837![]() (+64.72%) | Filing History |
| 2025-08-06 11:56 am Purchase | 2025-06-30 | 13G | CytomX Therapeutics, Inc. CTMX | FMR LLC | 9,238,868 5.900% | 7,100,090![]() (+331.97%) | Filing History |
| 2025-07-29 11:22 am Purchase | 2025-06-30 | 13G | CytomX Therapeutics, Inc. CTMX | VANGUARD GROUP INC | 9,379,794 5.950% | 4,476,851![]() (+91.31%) | Filing History |
| 2025-07-09 7:55 pm Sale | 2025-07-03 | 13G | CytomX Therapeutics, Inc. CTMX | BIOTECHNOLOGY VALUE FUND L P | 5,769,231 3.500% | -5,769,231![]() (-50.00%) | Filing History |
| 2025-07-09 7:53 pm Purchase | 2025-06-30 | 13G | CytomX Therapeutics, Inc. CTMX | BIOTECHNOLOGY VALUE FUND L P | 11,538,462 6.800% | 3,448,667![]() (+42.63%) | Filing History |
| 2025-05-20 9:02 pm Purchase | 2025-05-13 | 13G | CytomX Therapeutics, Inc. CTMX | Seven Fleet Partners LP | 377,161 0.200% | 377,161![]() (New Position) | Filing History |
| 2025-05-20 9:00 pm Purchase | 2025-05-13 | 13G | CytomX Therapeutics, Inc. CTMX | Longitude Capital Partners V, LLC | 11,538,461 7.300% | 11,538,461![]() (New Position) | Filing History |
| 2025-05-20 4:25 pm Purchase | 2025-05-13 | 13G | CytomX Therapeutics, Inc. CTMX | Venrock Healthcare Capital Partners III, L.P. | 12,992,500 8.200% | 12,992,500![]() (New Position) | Filing History |
| 2025-05-15 4:15 pm Sale | 2025-03-31 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL MANAGEMENT, LLC | 6,717,825 8.400% | -1,093,935![]() (-14.00%) | Filing History |
| 2025-05-14 5:14 pm Purchase | 2025-05-12 | 13G | CytomX Therapeutics, Inc. CTMX | Point72 Asset Management, L.P. | 13,094,400 8.300% | 13,094,400![]() (New Position) | Filing History |
| 2025-02-14 11:34 am Sale | 2024-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -4,809,518![]() (Position Closed) | Filing History |
| 2024-11-14 4:26 pm Purchase | 2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX | BIOTECHNOLOGY VALUE FUND L P | 8,089,795 9.990% | 1,386,906![]() (+20.69%) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL MANAGEMENT, LLC | 7,811,760 9.990% | 7,811,760![]() (New Position) | Filing History |
| 2024-11-14 3:03 pm Sale | 2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX | Cormorant Asset Management, LP | 0 0.000% | -5,750,000![]() (Position Closed) | Filing History |
| 2024-11-14 12:28 pm Purchase | 2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX | JANUS HENDERSON GROUP PLC JHG | 4,809,518 6.200% | 651,408![]() (+15.67%) | Filing History |

